Search

Author/Creator Turkington, Richard C.

3. Dual Erb B Inhibition in Oesophago-gastric Cancer (DEBIOC): A phase I dose escalating safety study and randomised dose expansion of AZD8931 in combination with oxaliplatin and capecitabine chemotherapy in patients with oesophagogastric adenocarcinoma. (January 2020)

Authors:
Thomas, Anne; Virdee, Pradeep S.; Eatock, Martin; Lord, Simon R.; Falk, Stephen; Anthoney, D. Alan; Turkington, Richard C.; Goff, Matthew; Elhussein, Leena; Collins, Linda; Love, Sharon; Moschandreas, Joanna; Middleton, Mark R.
Journal:
European journal of cancer
Issue:
Volume 124(2020)
Page Start:
131
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Mismatch Repair and Microsatellite Instability Testing for Immune Checkpoint Inhibitor Therapy: ASCO Endorsement of College of American Pathologists Guideline. Issue 10 (1st April 2023)

Authors:
Vikas, Praveen; Messersmith, Hans; Compton, Carolyn; Sholl, Lynette; Broaddus, Russell R.; Davis, Anjee; Estevez-Diz, Maria; Garje, Rohan; Konstantinopoulos, Panagiotis A.; Leiser, Aliza; Mills, Anne M.; Norquist, Barbara; Overman, Michael J.; Sohal, Davendra; Turkington, Richard C.; Johnson, Tyler
Journal:
Journal of clinical oncology
Issue:
Volume 41:Issue 10(2023)
Page Start:
1943
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗